Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Immunologic research

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12026-016-8867-xPMID 27618830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of anti–HMG‐CoA reductase autoantibodies in severe self‐limited statin‐related myopathy

  2016cited by this paper
• Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis

  2016cited by this paper
• Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

  2016cited by this paper
• Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.

  2015cited by this paper
• Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management

  2015cited by this paper
• Immune Mediated Myopathy following Long-Term Statin Therapy.

  2015cited by this paper
• Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy

  2015cited by this paper
• Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies

  2015cited by this paper
• Clinical and genetic associations of autoantibodies to 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme a reductase in patients with immune‐mediated myositis and necrotizing myopathy

  2015cited by this paper
• Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies

  2014cited by this paper
• Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

  2014cited by this paper
• Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology

  2014cited by this paper
• Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies

  2014cited by this paper
• Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies

  2013cited by this paper
• Statin‐associated autoimmune myopathy and anti‐HMGCR autoantibodies

  2013cited by this paper
• Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.

  2013cited by this paper
• The spectrum of statin myopathy

  2013cited by this paper
• Isolated necrotizing myopathy associated with ANTI‐PL12 antibody

  2012cited by this paper
• Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl‐coenzyme A reductase–associated autoimmune myopathy

  2012cited by this paper
• Necrotizing myopathy: Clinicoserologic associations

  2012cited by this paper
• Rarity of anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in statin users, including those with self‐limited musculoskeletal side effects

  2012cited by this paper
• Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

  2012cited by this paper
• Review: An update on inflammatory and autoimmune myopathies

  2011cited by this paper
• Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

  2011cited by this paper
• A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

  2010cited by this paper
• INFLAMMATORY MYOPATHIES

  2006cited by this paper
• Periodic limb movement syndrome

  2002cited by this paper
• Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature.

  2000cited by this paper
• Polymyositis, dermatomyositis and inclusion-body myositis.

  1991cited by this paper
• Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

  1983cited by this paper
• Inflammatory myopathies.

  1982cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Polymyositis and dermatomyositis (second of two parts).

  1975cited by this paper

• Autoantibody testing in neuromuscular medicine: assay technologies, interpretation, and clinical utility.

  2026cites this paper
• Effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitors in managing hypercholesterolemia post-statin-associated immune-mediated necrotizing myopathy: report of five cases and literature review

  2025cites this paper
• Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied Patient

  2025influential citation
• Progressive Muscle Weakness: Identifying Necrotizing Autoimmune Myopathy as a Rare Culprit

  2025cites this paper
• Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy

  2025cites this paper
• Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments.

  2024cites this paper
• Development of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase autoantibodies using a non‐radioactive biotinylated recombinant protein

  2024cites this paper
• Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies

  2023cites this paper
• A tough pill to swallow: Two cases of statin-induced necrotizing autoimmune myopathy manifesting as dysphagia and transaminitis

  2023cites this paper
• Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.

  2022cites this paper
• Statin-Associated Autoimmune Myopathy: Review of the Literature

  2022cites this paper
• Generalised oedema as a presenting manifestation of inflammatory myopathy

  2022cites this paper
• Necrotising myopathy and concurrent thyroiditis in a patient with COVID-19 infection

  2021cites this paper
• Paraneoplastic myopathy in pancreatic cancer: a case report and literature review

  2021cites this paper
• Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy

  2021influential citation
• Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study

  2020cites this paper
• Statin-Associated Autoimmune Myopathy: Current Perspectives

  2020cites this paper
• Immune mediated necrotizing myopathy: A rare complication of statin therapy

  2020cites this paper
• Statin Associated Autoimmune Myonecrosis: Case Report With Delayed Onset and Treatment Challenges

  2020cites this paper
• Immune-mediated necrotizing myopathy: clinical features and pathogenesis

  2020cites this paper
• A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features.

  2020cites this paper
• Pathophysiologic Insights from Biomarker Studies in Neurological Disorders

  2020cites this paper
• TCRM_A_197941 483..492

  2020cites this paper
• Somatosensory amplification, depression, anxiety and pain in statin intolerant patients

  2019cites this paper
• Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: An Unusual Presentation.

  2019cites this paper
• Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies

  2019cites this paper
• Statins and Immune-Mediated Necrotizing Myopathy

  2019cites this paper
• Drug-Induced Autoimmunity

  2019cites this paper
• Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.

  2019cites this paper
• Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

  2019cites this paper
• Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review

  2018cites this paper
• Immunopathological Characterization of Muscle Biopsy Samples from Immune-Mediated Necrotizing Myopathy Patients

  2018cites this paper
• Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy

  2018cites this paper
• Autoimmune necrotising myopathy and HMGCR antibodies

  2018cites this paper
• Animal models in idiopathic inflammatory myopathies: How to overcome a translational roadblock?

  2017cites this paper
• Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west.

  2017influential citation
• Novel clinical and therapeutic aspects in autoimmunity

  2016cites this paper